» Articles » PMID: 23894330

Rk1, a Ginsenoside, is a New Blocker of Vascular Leakage Acting Through Actin Structure Remodeling

Overview
Journal PLoS One
Date 2013 Jul 30
PMID 23894330
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial barrier integrity is essential for vascular homeostasis and increased vascular permeability and has been implicated in many pathological processes, including diabetic retinopathy. Here, we investigated the effect of Rk1, a ginsenoside extracted from sun ginseng, on regulation of endothelial barrier function. In human retinal endothelial cells, Rk1 strongly inhibited permeability induced by VEGF, advanced glycation end-product, thrombin, or histamine. Furthermore, Rk1 significantly reduced the vessel leakiness of retina in a diabetic mouse model. This anti-permeability activity of Rk1 is correlated with enhanced stability and positioning of tight junction proteins at the boundary between cells. Signaling experiments revealed that Rk1 induces phosphorylation of myosin light chain and cortactin, which are critical regulators for the formation of the cortical actin ring structure and endothelial barrier. These findings raise the possibility that ginsenoside Rk1 could be exploited as a novel prototype compound for the prevention of human diseases that are characterized by vascular leakage.

Citing Articles

Natural remedies proposed for the management of diabetic retinopathy (DR): diabetic complications.

Khidr E, Morad N, Hatem S, El-Dessouki A, Mohamed A, El-Shiekh R Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39954069 DOI: 10.1007/s00210-025-03866-w.


Structural Characters and Pharmacological Activity of Protopanaxadiol-Type Saponins and Protopanaxatriol-Type Saponins from Ginseng.

Zhang L, Gao X, Yang C, Liang Z, Guan D, Yuan T Adv Pharmacol Pharm Sci. 2024; 2024:9096774.

PMID: 38957183 PMC: 11217582. DOI: 10.1155/2024/9096774.


Systematic review and Meta-analysis of 26 randomized controlled clinical trials of Compound Danshen Dripping Pill for non-proliferating diabetic retinopathy.

Wang Y, Hao L, Huo Z, Liu Y, Sun Y, Song Z Chin Herb Med. 2022; 14(1):142-153.

PMID: 36120120 PMC: 9476495. DOI: 10.1016/j.chmed.2021.08.002.


A cortactin CTTN coding SNP contributes to lung vascular permeability and inflammatory disease severity in African descent subjects.

Belvitch P, Casanova N, Sun X, Camp S, Sammani S, Brown M Transl Res. 2022; 244:56-74.

PMID: 35181549 PMC: 9119916. DOI: 10.1016/j.trsl.2022.02.002.


Ginsenoside Rk1 is a novel inhibitor of NMDA receptors in cultured rat hippocampal neurons.

Ryoo N, Rahman M, Hwang H, Ko S, Nah S, Kim H J Ginseng Res. 2020; 44(3):490-495.

PMID: 32372871 PMC: 7195591. DOI: 10.1016/j.jgr.2019.04.002.


References
1.
Ehringer W, Edwards M, MILLER F . Mechanisms of alpha-thrombin, histamine, and bradykinin induced endothelial permeability. J Cell Physiol. 1996; 167(3):562-9. DOI: 10.1002/(SICI)1097-4652(199606)167:3<562::AID-JCP20>3.0.CO;2-4. View

2.
Sengupta S, Toh S, Sellers L, Skepper J, Koolwijk P, Leung H . Modulating angiogenesis: the yin and the yang in ginseng. Circulation. 2004; 110(10):1219-25. DOI: 10.1161/01.CIR.0000140676.88412.CF. View

3.
Papapetropoulos A . A ginseng-derived oestrogen receptor beta (ERbeta) agonist, Rb1 ginsenoside, attenuates capillary morphogenesis. Br J Pharmacol. 2007; 152(2):172-4. PMC: 1978256. DOI: 10.1038/sj.bjp.0707360. View

4.
Weis S, Cheresh D . Pathophysiological consequences of VEGF-induced vascular permeability. Nature. 2005; 437(7058):497-504. DOI: 10.1038/nature03987. View

5.
Min J, Kim J, Cho Y, Maeng Y, Lee S, Pyun B . 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. Biochem Biophys Res Commun. 2006; 349(3):987-94. DOI: 10.1016/j.bbrc.2006.08.129. View